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Purpose: Usher syndrome type II (USH2) is the most common form of Usher syndrome, an autosomal recessive disorder
characterized by moderate to severe hearing loss, postpuberal onset of retinitis pigmentosa (RP), and normal vestibular
function. Mutations in the USH2A gene have been shown to be responsible for most cases of USH2. To further elucidate
the role of USH2A in USH2, mutation screening was undertaken in three Chinese families with USH2.
Methods: Three unrelated Chinese families, consisting of six patients and 10 unaffected relatives, were examined
clinically, and 100 normal Chinese individuals served as controls. Genomic DNA was extracted from the venous blood
of all participants. The coding region (exons 2–72), including the intron-exon boundary of USH2A, was amplified by
polymerase chain reaction (PCR). The PCR products amplified from the three probands were analyzed using direct
sequencing to screen sequence variants. Whenever substitutions were identified in a patient, restriction fragment length
polymorphism analysis, or single strand conformation polymorphism analysis was performed on all available family
members and the control group.
Results: Fundus examination revealed typical fundus features of RP, including narrowing of the vessels, bone-speckle
pigmentation, and waxy optic discs. The ERG wave amplitudes of three probands were undetectable. Audiometric tests
indicated moderate to severe sensorineural hearing impairment. Vestibular function was normal. Five novel mutations
(one small insertion, one small deletion, one nonsense, one missense, and one splice site) were detected in three families
after sequence analysis of USH2A. Of the five mutations, four were located in exons 22–72, specific to the long isoform of
USH2A.
Conclusions: The mutations found in our study broaden the spectrum of USH2A mutations. Our results further indicate
that the long isoform of USH2A may harbor even more mutations of the USH2A gene.
Usher  syndrome  (USH)  is  an  autosomal  recessive
disorder  characterized  by  retinitis  pigmentosa  (RP)  and
sensorineural hearing impairment, with or without vestibular
dysfunction. It is a clinically and genetically heterogeneous
condition. Clinically, USH is subdivided into three types:
USH type I (USH1), USH type II (USH2), and USH type III
(USH3).  USH1  is  the  most  severe  form  of  this  disease
characterized by congenital profound hearing loss, prepuberal
onset of RP, and vestibular dysfunction. Patients with USH2
experience congenital moderate to severe hearing impairment
and postpuberal onset of RP with intact vestibular function.
Patients with USH3 show progressive postlingual hearing
loss, later onset of RP, and variable vestibular dysfunctions.
Of the three clinical types, USH2 is the most common form
of USH, and it may account for more than half of the patients
with USH [1,2]. To date at least 11 chromosome loci have
been mapped for the three clinical USH types. Three of them
are assigned to USH2: USH2A (USH2A), USH2C (VLGRI),
and USH2D (DFNB31) [1,3-5].
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The USH2A gene located on chromosome 1q41 has two
alternatively spliced isoforms: a short USH2A isoform a and
a much longer USH2A isoform b. In 1998, USH2A isoform a
was first identified and found to contain 21 exons encoding a
protein of 1,546 amino acids [6]. However, in 2004, van Wijk
et  al.  [7]  identified  51  additional  exons  at  the  3′  end  of
USH2A. The longer USH2A alternative splicing isoform b,
comprised of 72 exons, encodes a putative protein of 5,202
amino  acids.  USH2A  isoform  a  is  thought  to  be  an
extracellular matrix protein involved in protein–protein or
protein-matrix  interactions,  while  USH2A  isoform  b  is  a
transmembrane protein [3,8]. In the inner ears of mice and
rats, USH2A isoform b is a component of the ankle links that
connect the differentiating stereocilia of the hair cells [9]. In
the  photoreceptor,  it  is  an  essential  partner  of  a  protein
network that is likely to be involved in cargo delivery from
the inner segment to the outer segment [10]. USH2A is thought
to be involved in 74 to 90 percent of cases of USH2 [11].
Moreover, mutations of USH2A could also be responsible for
atypical USH and nonsyndromic RP [11-13].
In  this  study,  we  performed  a  mutation  screening  of
USH2A corresponding to USH2A isoform b. The screening
was done in three Chinese families who were affected with
USH2, and we identified five novel mutations.
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Clinical data and sample collection: This study was granted
approval by the Beijing Tongren Hospital Joint Committee on
Clinical  Investigation  and  conformed  to  the  tenets  of  the
Declaration of Helsinki. Three Chinese families with USH2
were referred to Beijing Tongren Hospital. After informed
consent  was  obtained  from  each  family  member,  all
participants  underwent  careful  clinical  examinations,
including  best-corrected  visual  acuity,  slit-lamp,  and
ophthalmoscope. Three probands of the families were given
electroretinograms and they also received audiometric and
vestibular tests. Full field electroretinogram were performed
according  to  International  Society  for  Clinical
Electrophysiology of Vision (ISCEV) protocols. USH2 was
diagnosed based on the clinical history, typical RP fundus
appearance,  sensorineural  hearing  impairment,  and  intact
vestibular function.
Mutation detection: Blood samples of all participants were
obtained by venipuncture and genomic DNA was extracted
by  standard  phenol  protocols.  Mutation  screening  was
performed in the three families using direct DNA sequence
analysis. The coding region (exons 2–72) of USH2A was
amplified by polymerase chain reaction (PCR) in the probands
of the three families. The pairs of primers for exons 2–21 were
used as designed by Weston et al. [11], except those for exons
6 and 7. Those for exons 22–72 were used as described by van
Wijk et al. [7], except those for exons 41, 53, 63, 64, and 71
(Appendix  1).  For  direct  sequencing,  PCR  products  were
purified (Shenneng Bocai PCR purification kit; Shenneng,
Shanghai, China). The purified PCR products were sequenced
using an automatic fluorescence DNA sequencer (ABI, Prism
373A;  Perkin  Elmer,  Foster  City,  CA),  according  to  the
manufacturer’s  instructions.  Nucleotide  sequences  were
compared  with  the  published  cDNA  sequence  of  USH2A
(GenBank  NM_206933.1).  For  USH2A  gene  cDNA
numbering  +1  corresponds  to  A  in  the  ATG  translation
initiation codon in RefSeq (AY481573.1).
Restriction fragment length polymorphism (RFLP) analysis:
Variations found in the sequencing were confirmed with the
restriction  endonucleases  TaqaI,  MslI,  and  EcoRV  (New
England Biolabs, Ipswich MA), which were used with all
available  family  members  and  100  normal  controls.  The
reaction was performed in a 10 µl volume containing 9.4 µl
PCR product, 0.1 μl BSA (100 μg/ml), and 0.5 μl enzyme (4 U/
μl). The reaction was incubated overnight at 65 °C for TaqaI
and 37 °C for MslI and EcoRV. Afterwards the whole digest
was run on a 1% agarose gel and visualized under ultraviolet
light.
Single strand conformation polymorphism: For the sequence
variants that did not change (create or erase) a restriction site,
single strand conformation polymorphism (SSCP) was used
with all available family members and the control group. As
the PCR fragments used in SSCP analysis were between 150
to 300 bp, two pairs of specific primers were designed for
detecting the mutation in exons 43 and 61 (Appendix 1).
Amplified  DNA  was  mixed  with  an  equal  volume  of
formamide buffer: 95% formamide, 10 mM EDTA, 0.1%
bromophenol  blue,  and  0.1%  xylene  cyanol.  Denatured
samples  were  electrophoresed  on  a  16%  nondenaturing
polyacrylamide gel, with an acrylamide:bisacrylamide ratio
of 49:1, for 12–16 h at 300 v and 4 °C, before gels were silver-
stained and analyzed.
Prediction of splice scores: A Splice View program was used
to assess the possibility that intron sequence variants could
create or exclude splice sites. The program is accessible at
splice.
RESULTS
We  have  identified  three  unrelated  Chinese  families
consisting  of  six  patients  diagnosed  with  USH2  and  10
unaffected relatives. The inheritance pattern in these three
families  was  autosomal  recessive  (Figure  1).  All  of  the
patients  experienced  night  blindness,  vision  acuity
impairment,  and  moderate  to  severe  hearing  loss.
Ophthalmoscopic examination demonstrated attenuation of
the  retinal  vessels,  bone-speckle  pigmentation  in  the
midperiphery of the fundus, and waxy pallor of the optic nerve
head (Figure 2). The ERG wave amplitudes of three probands
were  indistinguishable  from  baseline  (data  not  shown).
Figure 1. Pedigree of the three Chinese families with Usher syndrome
type  II  who  had  mutations  in  USH2A.  Males  and  females  are
represented by squares and circles, respectively. The symbols for
affected family member are filled. The symbols for deceased family
members have a slash. The symbols for proband have an arrow. The
genotype  of  each  evaluated  individual  is  shown  below  the
individuals’ symbol and identification number. Abbreviations: Wild
type  (+);  c.8559-2A>G  (M1);  p.T3936P  (M2);  p.R34fs  (M3);
p.S2828fs (M4); p.W3150X (M5).
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hearing impairment. Vestibular function was normal. Detailed
clinical  information  on  affected  family  members  is
summarized in Table 1.
Sequencing of USH2A revealed 17 sequence variants in
this study, five of which were predicted to be pathogenic
mutations (Table 2). All five disease-causing mutations were
heterozygous and were first detected in our study (Figure 3).
Mutation c.8559–2A>G was identified in two families, and
the other four mutations (p.T3936P, p.R34fs, p.S2828fs, and
p.W3150X) were only detected in one patient or in in one
family. Using RFLP or SSCP analysis, we confirmed the five
mutations cosegregated with the USH2 phenotype (Figure 1,
Figure 4, and Figure 5), but we did not detect them in 100
normal controls.
Three different combinations of heterozygous mutations
were observed in the three families. In families F3 and F4, one
allele harbored the same splice site mutation c.8559–2A>G;
Figure 2. Fundus appearance of a patient with Usher syndrome type II. Fundal photographs from a proband (family F5) show typical retinal
degeneration with attenuation of the retinal vessels, irregular pigment clumps in the retina, and waxy pallor of the optic nerve head.





















F3 73021 FC/PL 14 RP 10 Moderate (SP) Wave undetectable Normal
F4 73034 0.3/0.2 15 RP congenital Moderate (SP) N/A Normal
73036 FC/ PL 14 RP congenital Severe (SP) Wave undetectable Normal
F5 73041 HM/HM 14 RP congenital Severe (SP) Wave undetectable Normal
73045 HM/HM 10 RP congenital Severe (SP) N/A Normal
73046 0.1/0.1 14 RP congenital Moderate (SP) N/A Normal
Abbreviations: R, right eye; L, left eye; FC, finger counting; PL, perception of light; HM, hand motion; SP, slight progressive;
N/A, data not available.
TABLE 2. NOVEL MUTATIONS IN USH2A IDENTIFIED IN THIS STUDY.
DNA change Exon Protein change Type of nucleotide change Family number Frequency
c.99_100insT 2 p.R34fs Heterozygous F4 0/200
c.8483delC 42 p.S2828fs Heterozygous F5 0/200
c.8559–2A>G 43 Exon43DEL Heterozygous F3,F4 0/200
c.9450G>A 48 p.W3150X Heterozygous F5 0/200
c.11806A>C 61 p.T3936P Heterozygous F3 0/200
The "Frequency" column, shows the number of chromosomes.
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2069Figure 3. Direct sequencing analysis of
the coding region of the USH2A gene.
A: Left, heterozygous one base insertion
mutation  c.99_100insT  (p.R34fs)
detected  in  patient  073036;  right,  the
corresponding  wild-type  sequence.  B:
left, Sequence shows the heterozygous
one base deletion mutation c.8483delC
(p.S2828fs) identified in patient 073041
and right, the corresponding wild type
sequence.  C:  Sequence  presents  the
heterozygous  nonsense  mutation  c.
9450G>A  (p.W3150X)  detected  in
patient 073041. D: Sequence shows the
heterozygous  missense  mutation  c.
11806A>C  (p.T3936P)  identified  in
patient  073021.  E:  upper,  Sequence
presents the heterozygous splicing site
mutation  c.8559-2A>G  identified  in
patient  073021,  lower,  the
corresponding  complimentary  strand
sequence.
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2070the  other  allele  carried  a  missense  mutation  c.11806A>C
(p.T3936P)  and  a  small  insert  mutation  c.99_100insT
(p.R34fs), respectively. Splice site prediction software online
(splice) was used, and c.8559–2A>G was predicted to abolish
the splice accept site of exon 43, which would lead to the
skipping of exon 43. In family F5, one allele harbored a
deletion mutation c.8483delC (p. S2828fs), while the other
allele carried a nonsense mutation c.9450G>A (p.W3150X).
In addition to the five pathogenic mutations detected in
this  study,  12  nonpathogenic  sequence  variants  were
identified. Four of these were novel, including two silent
variants  (c.879T>G/p.=and  c.1935A>T/p.=),  one  intron
variant  (c.10388–27T>C),  and  one  missense  variant  (c.
9340C>T/p.P3114S). Analysis by the online splice prediction
software  indicated  that  variant  c.10388–27T>C  did  not
disrupt any splice donor site or accept site, and it didn’t create
a new splice site. Although p.P3114S was detected in family
F5 and cosegregated in family members with the disease in
the family, it occurred both in the nonfunction domain and
nonconserved region of USH2A isoform b. Furthermore, it
was also identified in two individuals among the 100 normal
controls. It was classified as a nonpathogenic variant. Table 3
summarizes these variants on the basis of their nature and
frequency.
DISCUSSION
In  this  study,  we  examined  three  Chinese  families  with
clinically diagnosed USH and screened the USH2A gene. We
Figure 4. Restriction fragment length analysis on the three mutations
detected in this study. A: c.99_100insT created a TaqaI restriction
site that cosegregated with the affected individuals and the carriers
(370 bp, 470 bp, and 840 bp), but not with unaffected individuals and
normal controls (840bp). B: c.8483delC created an MslI restriction
site that cosegregated with the affected individuals and the carriers
(150 bp, 340 bp, and 490 bp), but not with unaffected individuals and
normal control (490 bp). C: c.9450G>A created an EcoRV restriction
site that cosegregated with the affected individuals and the carriers
(265 bp, and 530 bp), but not with unaffected individuals and normal
control (530 bp). Participant identification number is given above
each lane. N represents the normal control, and M refers to the DNA
ladder in bp.
identified five novel mutations in the three families, which
included three point mutations, one insertion mutation, and
one deletion mutation. As shown in Figure 1, the three families
carried different compound heterozygous mutations, which
were  consistent  with  a  pattern  of  autosomal  recessive
inheritance  of  USH.  Although  all  affected  individuals
experienced progressive hearing loss, the progression was
slight, which was not as evident as it was in USH3. The clinical
phenotype could be considered to be USH2.
As shown in Figure 6, USH2A isoform b consists of eight
domains: N-terminal signal peptide, laminin G-like domain
(Lam GL), laminin N-terminal (Lam NT), laminin-type EGF-
like domain (EGF Lam), fibronectin type III (FN3), laminin
G  domains  (LamG),  transmembrane  region  (TM),  and
cytoplasmic  domain  with  a  PDZ-binding  motif  at  its  C-
terminal end [7]. Four novel truncating mutations (p.R34fs,
p.S2828fs, p.W3150X, and c.8559–2A>G), either directly or
indirectly  result  in  premature  termination  of  USH2A
translation or lead to deletion of more than one amino acid
residue. This may cause significant changes in the primary
protein structure. The c.99_100insT results in a frameshift at
codon  34  and  premature  stop  codon  8  amino  acids
downstream, which removes almost all protein except for the
N-terminal signal peptide. The c.8483delC, located in the 14th
FN3 repeat, causes a frameshift at codon 2828 and a premature
stop codon 1 amino acid downstream. The nonsense mutation
c.9450G>A leads to a premature stop codon at 3150. As the
Figure 5. Single strand conformation polymorphism analysis for the
two  mutations  identified  in  the  current  study.  A:  Single  strand
conformation polymorphism (SSCP) analysis for the heterozygous
mutation c. 8559–2A>G revealed that the mutant pattern (two bands)
cosegregated with the affected individuals and carriers, but not with
the unaffected individuals and normal control (one band). B: SSCP
analysis for c.11806A>C (p.T3936P) showed that the mutant pattern
(three bands) cosegregated with the affected individuals and carriers,
but not with the unaffected individuals and normal control (two
bands). Participant identification number is listed above each lane.
N represents the normal control.
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2071three premature stop codons are not located in the last exon of
USH2A, there is a possibility that nonsense-mediated mRNA
decay  might  be  involved  in  abnormal  RNA  processing.
Nonsense-mediated mRNA decay is a widespread cellular
process  that  proofreads  nascent  mRNA  transcripts  and
destroys those that bear premature termination codons before
they  are  actually  translated  into  truncated  and  potentially
harmful proteins [14]. The splicing variant c.8559–2 A>G
may result in the skipping of exon 43 of USH2A. The skipping
of exon 43 doesn’t result in the interruption of the reading
frame. However, it results in the deletion of 41 amino acids,
which encode most regions of the 15th FN3 repeat.
Unlike the mutations that cause the loss of a large part of
the protein, most of the amino acid substitutions occur at
highly  conserved  sites  and  result  in  significant  change  in
Figure 6. Schematic distribution shows the five novel mutations
identified in the current study along the USH2A isoform b protein
domains.  Abbreviation:  EGF-like  domain  (EGF  Lam); 
Transmembrane region (TM); Laminin G-like domain (Lam GL);
Fibronectin type III (FN3); PDZ-binding motif (PBM); Laminin N-
terminal (Lam NT); Laminin G domains (Lam G).
polarity or charge. The p.T3936 is located in the 21 FN3 repeat
and is highly conserved in humans, mice, chicks, and dogs.
The  only  missense  mutation  of  p.T3936P  (c.11806A>C)
replaces  a  polar  threonine  with  a  nonpolar  hydrophobic
proline (Figure 7).
To date, more than 160 mutations have been reported in
USH2A; however, mutation screening for Chinese patients
was  performed  only  once  (the  USH2A  gene;  Universal
Mutation Database, UMD). Liu et al. [12] only screened the
c.2299delG mutation in five Chinese families with USH2 and
atypical  USH  and  detected  one  homozygous  and  one
heterozygous c.2299delG. This is the first report to describe
mutation analysis of the complete coding sequence of USH2A
in  the  Chinese  population.  The  c.2299delG  was  the  most
common mutation with an allele frequency of 14–50% in
patients from Europe and North America [6,11-13,15-19].
Dreyer et al. [20] found that c.2299delG was the result of an
ancestral mutation that had spread throughout Europe and into
the New World as a result of migration. The c.2299delG was
Figure  7.  Sequence  alignment  portion  of  the  21  FN3  domain
spanning the novel missense mutation p.T3936P of human USH2A
isoform b with other species. Identical residues are highlighted in
purple. Arrow marks the identified mutation.
TABLE 3. PRESUMED NONPATHOGENIC VARIANTS FOUND IN USH2A.
Exon Nucleotide change Codon change
Family
number Allele frequency Source
6 c.879T>G p.L293L F5 N/A This study
11 c.1935A>T p.T645T F5 N/A This study
18 IVS17–8T>G F5 N/A [11]
21 c.4457A>G p.K1486R F5 76/180 [11]
34 c.6506T>C p.I2169T F3,F4,F5 27/100 [16]
47 c.9340C>T p.P3114S F5 2/200 This study
52 c.10232A>C p.E3411A F3,F4,F5 23/64* [17]
53 IVS52–27T>C F3,F4,F5 N/A This study
60 c.11602A>G p.M3868V F5 8/64* [17]
63 c.12612A>G p.T4204T F3,F4,F5 N/A [17]
c.12666A>G p.T4222T F5 14/64* [17]
c.13191G>A p.E4397E F3,F4,F5 7/64* [17]
Abbreviations: N/A, data not available; the asterisk indicates that the allele frequency referred to patients sample.
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2072only detected in single patients from South America, South
Africa, and China [12,20]. It was not identified in the current
study. As we only underwent mutation screening for three
families, it is difficult to reach the conclusion that c.2299delG
is a low frequency allele in the Chinese patients.
Of the five novel mutations detected in the current study,
four are located in exons 22–72, which are specific to the long
isoform  of  USH2A.  Two  families  (F3  and  F5)  carrying
compound heterozygous mutations (either two truncating or
one truncating combined with one missense) in exons 22–72,
presented with the USH2 phenotype. This is in accordance
with Dreyer’s observation in a large unrelated Scandinavian
patients study [21].
In conclusion, we have described five novel mutations in
three Chinese families with USH2. Our findings expand the
spectrum of UHS2A mutations in USH and disclose that the
long isoform of USH2A may harbor even more mutations of
the USH2A gene.
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2074Appendix 1. PCR primers used in this study
Oligonucleotide primers used for PCR amplification and
sequencing of USH2A. To access the data, click or select the
words “Appendix 1.” This will initiate the download of a pdf
archive that contains the file.
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